Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

École Polytechnique de Montréal

$33,000.00

3D Dynamic Ultrasound Localization Microscopy

EF 2020-21

Résumé
Microvessels are the smallest blood vessels (<100 microns) in the body. They distribute blood, and thus oxygen and nutrients, within tissues, and their dysfunction is central to many of our most pressing healthcare challenges, from heart failure to diabetes and neurodegenerative diseases. The tools available to image the anatomy and the in vivo function of these vessels have been improving rapidly but remain limited in both the laboratory and clinical settings, which hampers our ability to devise novel diagnostic techniques and therapeutic approaches. 2D blood vessel imaging using ultrasound has undergone multiple breakthrough innovations over the past 10 years. Most recently, a novel technique inspired by super-resolved fluorescence microscopy called ultrasound localization microscopy (ULM) improved spatial resolution of the vasculature from hundreds to a few microns in vivo via the detection at thousands of frames per second of millions of individual microbubbles (approved for human use) injected in the blood stream, enabling the generation of vascular maps of unprecedented resolution with any imaging modality that can probe at large depth. ULM remains however currently limited to static angiographic images in 2D imaging planes, of which the thickness can reach up to 1 mm, despite a 5-um in-plane resolution. We have recently introduced two innovations to ULM: the capability of performing images in vivo in 1) three dimensions with isotropic resolution and 2) dynamically. Together, these innovations, we believe, will be game changers in the field: achieving true isotropic superresolution, i.e., 5X5X5 um3 instead of 5X5X1000 um3 as currently obtained by state-of the-art ULM, and providing a millisecond temporal resolution, enable the generation of biomarkers currently invisible to existing modalities. Our long-term vision is to develop, validate and demonstrate feasibility of novel instruments and methodologies based on 3D-DULM for enhanced diagnosis and treatment monitoring of diseases associated with microvascular abnormalities. Our short-term objectives aim to fundamentally quantify the trade-offs between imaging parameters and image quality in order to extract new biomarkers, propose novel instrumentation designs, and enable the pre-clinical and clinical translation of 3D-DULM. Our general approach consists in innovating in the field of physics and to disseminate rapidly to preclinical and clinical applications by implementing collaborations with biologists and clinicians. Our technologies are based on ultrasound and as such are intrinsically portable, non-invasive, relatively low-cost and translational, as most parts of our devices can be used from small animals to humans. As such, they can rapidly be integrated into existing protocols and lead to immediate impact.
Programme
Discovery Grants Program - Individual
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2020-06786
Name nom
Provost, Jean
Department département
Engineering Physics
Organization id
64
Institution établissement
École Polytechnique de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2020
Award amount
33000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1505
Committee name en
Physics
Committee name fr
Physique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Installment
inst:1-5
Partie
5
Nb partie
5
Application title
3D Dynamic Ultrasound Localization Microscopy
Keyword
NSERC
Application summary
Microvessels are the smallest blood vessels (<100 microns) in the body. They distribute blood, and thus oxygen and nutrients, within tissues, and their dysfunction is central to many of our most pressing healthcare challenges, from heart failure to diabetes and neurodegenerative diseases. The tools available to image the anatomy and the in vivo function of these vessels have been improving rapidly but remain limited in both the laboratory and clinical settings, which hampers our ability to devise novel diagnostic techniques and therapeutic approaches. 2D blood vessel imaging using ultrasound has undergone multiple breakthrough innovations over the past 10 years. Most recently, a novel technique inspired by super-resolved fluorescence microscopy called ultrasound localization microscopy (ULM) improved spatial resolution of the vasculature from hundreds to a few microns in vivo via the detection at thousands of frames per second of millions of individual microbubbles (approved for human use) injected in the blood stream, enabling the generation of vascular maps of unprecedented resolution with any imaging modality that can probe at large depth. ULM remains however currently limited to static angiographic images in 2D imaging planes, of which the thickness can reach up to 1 mm, despite a 5-um in-plane resolution. We have recently introduced two innovations to ULM: the capability of performing images in vivo in 1) three dimensions with isotropic resolution and 2) dynamically. Together, these innovations, we believe, will be game changers in the field: achieving true isotropic superresolution, i.e., 5X5X5 um3 instead of 5X5X1000 um3 as currently obtained by state-of the-art ULM, and providing a millisecond temporal resolution, enable the generation of biomarkers currently invisible to existing modalities. Our long-term vision is to develop, validate and demonstrate feasibility of novel instruments and methodologies based on 3D-DULM for enhanced diagnosis and treatment monitoring of diseases associated with microvascular abnormalities. Our short-term objectives aim to fundamentally quantify the trade-offs between imaging parameters and image quality in order to extract new biomarkers, propose novel instrumentation designs, and enable the pre-clinical and clinical translation of 3D-DULM. Our general approach consists in innovating in the field of physics and to disseminate rapidly to preclinical and clinical applications by implementing collaborations with biologists and clinicians. Our technologies are based on ultrasound and as such are intrinsically portable, non-invasive, relatively low-cost and translational, as most parts of our devices can be used from small animals to humans. As such, they can rapidly be integrated into existing protocols and lead to immediate impact.